How Americans Think and Feel About Their Medical Devices: New Survey Findings
Among 2000 US adults, a new survey found consumers prioritize trust and recommendations over brand loyalty in health tracking devices, prizing accuracy and reliability.
Guideline Topline: 14 Key Lifestyle Interventions to Treat, Prevent Type 2 Diabetes
These 14 recommendations from the American College of Lifestyle Medicine comprise the core of the first-ever guideline centered on lifestyle change as a first-line intervention.
ACOG 2025: Poster Highlights for Primary Care
Details on 12 key abstracts with clinical relevance for primary care, from menopause management to PPD screening and HPV testing.
Pertussis: A Brief Backgrounder for Primary Care
Cases of whooping cough in the US more than doubled in 2024, and 2 infants have died from the infection. Here is background on the infection and vaccine.
Signs of Alzheimer Disease vs Age-Related Changes
Occasional trouble finding a word reflects typical age-related brain changes; the changes that cause a person to refer to a watch as a "hand clock" are not the same.
Alzheimer Disease in 2025: American Perspectives
US adults want to know early on if they have Alzheimer disease, when treatment may slow it, and they are willing to participate in trials of new drugs.
Depression & Anxiety in Adults with Chronic Pain: A Meta-Analysis Review
Approximately 40% of adults with chronic pain have comorbid anxiety and/or depression, underscoring the importance of routine screening in this population.
False Beliefs about MMR Vaccine, Measles Reach the Majority of US Adults: KFF Poll on Health Information & Trust
Misinformation about measles and the MMR vaccine has reached the majority of US adults and parents; most believe the vaccine is safe but many are still unconvinced.
Immunization in America: Highs and Lows by State
A quick look at the states ranking highest and lowest on metrics including influenza vaccination, tetanus vaccination, HPV vaccination, and more.
Vaccination Attitudes in the US: Key Insights for Primary Care
A recent survey of US adults sheds light on public attitudes regarding RSV, influenza, COVID-19, MMR, and other key vaccines.
The Road to RSV Vaccines in the US: A Timeline Topline
Respiratory syncytial virus was deadly and untreatable across the lifespan until 2023 when the first vaccines were approved in the US. Follow the timeline, here.
10 Drugs Approved for Primary Care: Q1 2025
Review 10 new FDA-approved drugs that may soon find a place in your prescribing routine, including new treatments for UTIs, acute pain, and more.
9 Common Myths About Cancer Screening and the Facts for Your Patients Who Believe Them
Myths and fears about cancer screening may be keeping some of your patients from important tests. Always ask about misconceptions, and then offer the facts.
Diagnosis of Atrial Fibrillation: A Guideline Topline
This AF guideline topline offers an at-a-glance look at the most recent ACC/AHA guidance on diagnosis of the arrhythmia.
Measles is Dangerous in Adults: Who and How to Assess for the MMR Booster
The 2025 measles outbreak is predominantly affecting children, but measles is highly contagious and adults remain at risk, especially if they have not received the MMR vaccination.
The 10 States with the Highest Risk for Cancer
The greatest risk for developing cancer faces residents of South Dakota, where radon levels are the nation's highest, and ranks for alcohol consumption and obesity are poor.
US Adult Vaccination Snapshots: Current Coverage, Trends, and Concerns
Get the latest immunization updates, data on racial disparities, and practical guidance for clinical practice, here.
Dermatology Therapeutics: Updates for Primary Care from AAD 2025
Research included new findings on topical and systemic treatments for atopic dermatitis, psoriasis, alopecia areata, and other chronic skin disorders.
Advances in Dermatology Therapeutics: Key Insights from AAD 2025
Highlights include new data on roflumilast cream 0.15%, an investigational anti-OX40 ligand monoclonal antibody, and more.
Obesity Will Affect One-Half of Adults, One-Third of Youth Worldwide by 2050
Posing an unparalleled threat of premature disease and death globally, the unchecked rise in overweight and obesity requires an urgent 5-year action plan, experts say.